Cargando…
Sub-Optimal Adherence With Daily Growth Hormones Increases With Each Year of Treatment in a US Commercial Claims Database
Introduction and Objective: Pediatric growth hormone deficiency (pGHD) occurs in approximately 1 in 4,000 children. The main manifestation is short stature managed with daily injections of somatropin, a recombinant human growth hormone (r-hGH). Prior research has shown that children with good adhere...
Autores principales: | Loftus, Jane, Chen, Yong, Alvir, Jose Ma J, Chi, Lei, Dasgupta, Shibasish, Gupta, Anu, Wajnrajch, Michael P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090583/ http://dx.doi.org/10.1210/jendso/bvab048.1398 |
Ejemplares similares
-
ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022) -
Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022) -
RF26 | PSAT150 Growth Outcomes From the Phase 2 and Phase 3 Studies of Once Weekly Somatrogon vs Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency: Comparisons With Published Literature and an International Growth Study Database
por: Cara, Jose, et al.
Publicado: (2022) -
Identification of pregnancies and infants within a US commercial healthcare administrative claims database
por: Bertoia, Monica L., et al.
Publicado: (2022) -
Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)